Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors

Clinical trial NCT04990739 · UNKNOWN

Trial details

NCT number: NCT04990739
Sponsor: MetaboMed Inc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-06-30
Primary completion: 2024-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.